490 related articles for article (PubMed ID: 33806296)
1. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
Donini C; Rotolo R; Proment A; Aglietta M; Sangiolo D; Leuci V
Cells; 2021 Mar; 10(3):. PubMed ID: 33806296
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
3. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
4. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
[TBL] [Abstract][Full Text] [Related]
5. Immunologic Targeting of Cancer Stem Cells.
Zhang J; Li Q; Chang AE
Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.
Gammaitoni L; Leuci V; Mesiano G; Giraudo L; Todorovic M; Carnevale-Schianca F; Aglietta M; Sangiolo D
Expert Opin Biol Ther; 2014 Sep; 14(9):1259-70. PubMed ID: 24835841
[TBL] [Abstract][Full Text] [Related]
7. The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.
Miyamoto S; Kochin V; Kanaseki T; Hongo A; Tokita S; Kikuchi Y; Takaya A; Hirohashi Y; Tsukahara T; Terui T; Ishitani K; Hata F; Takemasa I; Miyazaki A; Hiratsuka H; Sato N; Torigoe T
Cancer Immunol Res; 2018 Mar; 6(3):358-369. PubMed ID: 29371260
[TBL] [Abstract][Full Text] [Related]
8. Engaging stemness improves cancer immunotherapy.
Dianat-Moghadam H; Sharifi M; Salehi R; Keshavarz M; Shahgolzari M; Amoozgar Z
Cancer Lett; 2023 Feb; 554():216007. PubMed ID: 36396102
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
10. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy.
Guo W; Qiao T; Li T
Semin Cancer Biol; 2022 Dec; 87():160-169. PubMed ID: 36371027
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells: Regulation programs, immunological properties and immunotherapy.
Zhang D; Tang DG; Rycaj K
Semin Cancer Biol; 2018 Oct; 52(Pt 2):94-106. PubMed ID: 29752993
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
Front Immunol; 2020; 11():140. PubMed ID: 32117287
[TBL] [Abstract][Full Text] [Related]
14. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
Xu Q; Liu G; Yuan X; Xu M; Wang H; Ji J; Konda B; Black KL; Yu JS
Stem Cells; 2009 Aug; 27(8):1734-40. PubMed ID: 19536809
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
18. Are ovarian cancer stem cells the target for innovative immunotherapy?
Wang L; Xu T; Cui M
Onco Targets Ther; 2018; 11():2615-2626. PubMed ID: 29780254
[TBL] [Abstract][Full Text] [Related]
19. Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy.
Klapdor R; Wang S; Hacker U; Büning H; Morgan M; Dörk T; Hillemanns P; Schambach A
Hum Gene Ther; 2017 Oct; 28(10):886-896. PubMed ID: 28836469
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
